Using the Phosflow method we demonstrated that the percentage of lymphocytes from patients with melanoma, particularly T cells, that phosphorylated STAT1 on tyrosine 701, and the mean fold change in intensity of STAT1-pY701 staining in response to IFN-α and IFN-β, were reduced compared to the healthy controls. The gene discussed is STAT1; the disease is melanoma.